BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
8.37
-0.08 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
8.37
0.06%
After-hours: Aug 15, 2025, 07:46 PM EDT
BioCryst Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -53.47M | -88.88M | -123.82M | -145.93M | -208.59M | -226.54M | -236.35M | -242.72M | -226.25M | -247.12M | -193.35M | -209.63M | -193.97M | -184.06M | -226.78M | -214.09M | -209.5M |
Depreciation & Amortization | 1.27M | 1.25M | 1.36M | 1.47M | 1.56M | 1.66M | 1.63M | 1.6M | 1.52M | 1.44M | 1.21M | 1.05M | 916K | 777K | 786K | 724K | 708K |
Stock-Based Compensation | 73.13M | 65.41M | 60.56M | 55.59M | 55.26M | 55.62M | 54.41M | 52.08M | 49.11M | 44.7M | 37.92M | 41M | 38.76M | 34.64M | 32.03M | 21.87M | 17.52M |
Other Working Capital | -49.25M | -871K | -1.15M | 1.8M | 1.68M | -2M | -9.04M | -1.29M | 5.5M | 5.84M | 27.58M | 21.23M | 12.95M | 7.48M | -6.12M | -25.38M | -26.38M |
Other Non-Cash Items | 54.11M | 57.48M | 63.55M | 69.45M | 103.25M | 106.05M | 132.5M | 130.41M | 98.11M | 98.07M | 72.06M | 68.18M | 62.21M | 54.2M | 37.81M | 24.41M | 13.11M |
Deferred Income Tax | n/a | n/a | 475K | -12.26M | -12.26M | -12.26M | -12.74M | n/a | n/a | n/a | -55.88M | -55.87M | -55.85M | -55.84M | 52K | 93K | 743K |
Change in Working Capital | -100.89M | -87.28M | -57.85M | -64.92M | -53.27M | -32.4M | -62.26M | -63.99M | -54.05M | -58.95M | -32.43M | -6.01M | -11.01M | 8.12M | 1.77M | -2.33M | 2.47M |
Operating Cash Flow | -25.85M | -52.02M | -55.73M | -83.87M | -101.31M | -95.14M | -110.07M | -122.62M | -131.56M | -161.85M | -170.46M | -161.29M | -158.95M | -142.16M | -154.34M | -169.32M | -174.95M |
Capital Expenditures | -1.03M | -1.12M | -1M | -1.93M | -2.24M | -2.17M | -2.14M | -1.33M | -1.1M | -1.35M | -1.93M | -2.12M | -2.69M | -2.38M | -1.43M | -1.24M | -497K |
Cash Acquisitions | n/a | n/a | 5.38M | -18.73M | -160K | n/a | -5.38M | 88.1M | 166.72M | 166.56M | 166.56M | 97.19M | n/a | n/a | 513K | 513K | 513K |
Purchase of Investments | -227.52M | -266.76M | -384.22M | -481.18M | -453.78M | -514.41M | -357.42M | -338.55M | -354.85M | -244.28M | -254.29M | -149.27M | -48.08M | -10.01M | -15.44M | -49.82M | -49.82M |
Sales Maturities Of Investments | 279.48M | 320.48M | 391.55M | 504.06M | 460.39M | 385.08M | 333.75M | 221.41M | 159.08M | 117.4M | 39.66M | 12.11M | 13.43M | 28.2M | 49.77M | 42.15M | 47.41M |
Other Investing Acitivies | -2.89M | -2.98M | -2.98M | -2.53M | -235K | -160K | 77.58M | 8.21M | -88.98M | -126.89M | -214.64M | -137.16M | -39.97M | -1.9M | 23.04M | -18.96M | -34.4M |
Investing Cash Flow | 50.93M | 52.59M | 6.32M | 20.95M | 4.37M | -131.5M | -25.81M | -118.47M | -196.88M | -128.24M | -216.57M | -139.28M | -37.34M | 15.8M | 48.34M | 6.53M | -2.91M |
Debt Repayment | -1.47M | -1.35M | -2.51M | -1.96M | -1.55M | -1.17M | n/a | 73.07M | 73.07M | 73.07M | 73.07M | n/a | n/a | n/a | 72.45M | 67.45M | 67.45M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.24M | -5.95M | -4.51M | -3.04M | 27.69M | 33.43M | 39.64M | 41.68M | 12.68M | 14.96M | 308.17M | 309.7M | 314.12M | 309.67M | 138.24M | 133.83M | 237.45M |
Financial Cash Flow | -4.18M | -5.76M | -4.91M | -4.96M | 26.36M | 32.48M | 39.86M | 114.96M | 85.75M | 88.03M | 431.25M | 359.7M | 364.12M | 359.67M | 211.12M | 201.71M | 305.33M |
Net Cash Flow | 20.75M | -6.12M | -53.42M | -67.58M | -70.47M | -193.79M | -95.85M | -126.23M | -242.26M | -201.5M | 44.45M | 59.36M | 167.95M | 233.39M | 105.19M | 39.01M | 127.48M |
Free Cash Flow | -27.29M | -53.55M | -57.13M | -86.2M | -103.56M | -97.31M | -112.21M | -123.95M | -132.67M | -163.2M | -172.39M | -163.41M | -161.64M | -144.54M | -155.77M | -170.56M | -175.44M |